Effect of Doorvadi Cream In Atopic Dermatitis (Paridagdha Chavi) in Childrens A single group study

Evaluation Of Efficacy Of Doorvadi Cream In Paridagdha Chavi W.S.R To Atopic Dermatitis In Paediatric Age Group-A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050626

Enrollment

196

Registered

2023-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1- Pre diagnosed case of atopic dermatitis 2- Having mild and moderate atopic dermatitis according to TIS Scoring

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: (1) lesions with oozing, (2) oral administration of corticosteroids, immunosuppressantâ??s, or antibiotics 4 weeks prior to study entry, (3) administration of topical glucocortecoids, immunosuppressantâ??s, or antibiotics, or phototherapy, 2 weeks prior to study entry, (4) burn or trauma on the lesions, (5) active skin diseases without AD, (6) renal or liver dysfunction, (7) other uncontrolled chronic diseases, (8) participation in other clinical trials within 1 month of enrollment, (9) inability to understand the written consent or to engage in this study due to mental impairment or other emotional or mental problems, and (10) judgment by experts that the potential subjectâ??s participation is inappropriate

Design outcomes

Primary

Measure	Time frame
Reduced rednessTimepoint: 7th day	—

Secondary

Measure	Time frame
TIS score reducedTimepoint: 15th & 45th day	—

Countries

India

Contacts

Public ContactDr Swapnil Raskar

Parul institute of ayurveda

neeraj.bvp.coa@gmail.com9650970307

Outcome results